melatonin has been researched along with Asymmetric Diabetic Proximal Motor Neuropathy in 11 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Melatonin was also well tolerated." | 3.01 | Adjuvant use of melatonin for relieving symptoms of painful diabetic neuropathy: results of a randomized, double-blinded, controlled trial. ( Mehrpooya, M; Mohammadi, Y; Sajedi, F; Shokri, M, 2021) |
| "Melatonin level was evaluated by measuring 24-hour urine 6-sulfatoxymelatonin levels." | 1.62 | Presence of Peripheral Neuropathy Does Not Affect Urine 6-Sulfatoxymelatonin Levels in Type 2 Diabetics. ( Cakin, S; Karakılıç, E; Kurt, K; Ocak, O, 2021) |
| "Melatonin dynamics were re-evaluated with respect to autonomic nervous system in diabetic patients with autonomic neuropathy who were diagnosed by the cardiovascular reflex tests, heart rate variability (HRV), and 24-hr blood pressure monitoring." | 1.33 | Melatonin levels decrease in type 2 diabetic patients with cardiac autonomic neuropathy. ( Aksoyek, S; Batur, MK; Deger, A; Erbas, B; Erbas, T; Kabakci, G; Koray, Z; Tutuncu, NB; Tutuncu, T; Yildirir, A, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 5 (45.45) | 2.80 |
| Authors | Studies |
|---|---|
| Oliveira-Abreu, K | 1 |
| Cipolla-Neto, J | 1 |
| Leal-Cardoso, JH | 1 |
| Ocak, Ö | 2 |
| Silan, F | 1 |
| Şahin, EM | 1 |
| Che, H | 1 |
| Li, H | 1 |
| Li, Y | 1 |
| Wang, YQ | 1 |
| Yang, ZY | 1 |
| Wang, RL | 1 |
| Wang, LH | 1 |
| Kurt, K | 1 |
| Karakılıç, E | 1 |
| Cakin, S | 1 |
| Shokri, M | 1 |
| Sajedi, F | 1 |
| Mohammadi, Y | 1 |
| Mehrpooya, M | 1 |
| Gurel-Gokmen, B | 1 |
| Ipekci, H | 1 |
| Oktay, S | 1 |
| Alev, B | 1 |
| Ustundag, UV | 1 |
| Ak, E | 1 |
| Akakın, D | 1 |
| Sener, G | 1 |
| Emekli-Alturfan, E | 1 |
| Yarat, A | 1 |
| Tunali-Akbay, T | 1 |
| Seyit, DA | 1 |
| Degirmenci, E | 1 |
| Oguzhanoglu, A | 1 |
| Negi, G | 2 |
| Kumar, A | 2 |
| Kaundal, RK | 1 |
| Gulati, A | 1 |
| Sharma, SS | 2 |
| Tutuncu, NB | 1 |
| Batur, MK | 1 |
| Yildirir, A | 1 |
| Tutuncu, T | 1 |
| Deger, A | 1 |
| Koray, Z | 1 |
| Erbas, B | 1 |
| Kabakci, G | 1 |
| Aksoyek, S | 1 |
| Erbas, T | 1 |
| O'Brien, IA | 1 |
| Lewin, IG | 1 |
| O'Hare, JP | 1 |
| Arendt, J | 1 |
| Corrall, RJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Association Between Plasma Melatonin and No-reflow[NCT03306303] | 1,700 participants (Actual) | Observational | 2014-01-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for melatonin and Asymmetric Diabetic Proximal Motor Neuropathy
| Article | Year |
|---|---|
Effects of Melatonin on Diabetic Neuropathy and Retinopathy.
Topics: Animals; Diabetes Complications; Diabetes Mellitus; Diabetic Neuropathies; Diabetic Retinopathy; Hum | 2021 |
1 trial available for melatonin and Asymmetric Diabetic Proximal Motor Neuropathy
| Article | Year |
|---|---|
Adjuvant use of melatonin for relieving symptoms of painful diabetic neuropathy: results of a randomized, double-blinded, controlled trial.
Topics: Aged; Analgesics; Central Nervous System Depressants; Comorbidity; Diabetes Mellitus, Type 2; Diabet | 2021 |
9 other studies available for melatonin and Asymmetric Diabetic Proximal Motor Neuropathy
| Article | Year |
|---|---|
Melatonin receptor gene polymorphisms as a risk factor in patients with diabetic peripheral neuropathy.
Topics: Diabetes Mellitus; Diabetic Neuropathies; Genetic Predisposition to Disease; Humans; Melatonin; Poly | 2022 |
Melatonin exerts neuroprotective effects by inhibiting neuronal pyroptosis and autophagy in STZ-induced diabetic mice.
Topics: Animals; Antioxidants; Autophagy; Autophagy-Related Protein 12; Beclin-1; Brain; Caspase 1; Cell Lin | 2020 |
Presence of Peripheral Neuropathy Does Not Affect Urine 6-Sulfatoxymelatonin Levels in Type 2 Diabetics.
Topics: Diabetes Mellitus, Type 2; Diabetic Neuropathies; Humans; Melatonin; Oxidative Stress | 2021 |
Melatonin improves hyperglycemia induced damages in rat brain.
Topics: Animals; Antioxidants; Brain; Brain Diseases, Metabolic; Diabetes Mellitus, Experimental; Diabetic N | 2018 |
Evaluation of Electrophysiological Effects of Melatonin and Alpha Lipoic Acid in Rats with Streptozotocine Induced Diabetic Neuropathy.
Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Diabetic Neuropathies; Disease Models, Animal; E | 2016 |
Functional and biochemical evidence indicating beneficial effect of Melatonin and Nicotinamide alone and in combination in experimental diabetic neuropathy.
Topics: Animals; Antioxidants; Blood Glucose; Body Weight; Diabetic Neuropathies; Disease Models, Animal; Do | 2010 |
Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF-κB and Nrf2 cascades.
Topics: Animals; Blotting, Western; Cyclooxygenase 2; Diabetic Neuropathies; Immunohistochemistry; In Situ N | 2011 |
Melatonin levels decrease in type 2 diabetic patients with cardiac autonomic neuropathy.
Topics: Autonomic Nervous System Diseases; Blood Pressure; Circadian Rhythm; Diabetes Mellitus, Type 2; Diab | 2005 |
Abnormal circadian rhythm of melatonin in diabetic autonomic neuropathy.
Topics: Aged; Autonomic Nervous System Diseases; Blood Glucose; Circadian Rhythm; Diabetes Mellitus; Diabeti | 1986 |